LinkedIn Profile

Access NeuroQuest historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:neuroquest 3070353 May 30th, 2019 12:00AM NeuroQuest 113 13.00 Open Biotechnology May 30th, 2019 01:46PM May 30th, 2019 01:46PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. Open Alzheimer's Disease, ALS Disease, Biomarkers, Diagnostics Open 17 Techelet (Sky) St. M.P. Misgav IL 20174 NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 17th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 16th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 15th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 14th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 13th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 12th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 11th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 10th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services
private:neuroquest 3070353 Feb 9th, 2018 12:00AM NeuroQuest 101 16.00 Open Biotechnology Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM NeuroQuest is developing biomarkers for the early and accurate diagnosis of Alzheimer’s and ALS Diseases. NeuroQuest's diagnostics are blood-based immune biomarkers in AD and ALS patients. Blood samples are processed by standard laboratory approaches to measure novel and patent pending aspects of the peripheral immune system that reflect the disease pathology and can be used for diagnosis, prognosis, and monitoring disease progression. These patented biomarkers may lead to a better understanding of the mechanism of neurodegenerative disease, leading to improved therapeutics. NeuroQuest is a portfolio company of the Trendlines Group, with additional investments from the Maryland-Israel Trendlines Fund, and the InterTech Group. NeuroQuest Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.